Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Generic Formulation Business	139.80B	115.16B	107.28B	96.20B	85.08B
Generic Formulation Business Growth	21.39%	7.35%	11.51%	13.07%	6.29%
Total	139.80B	115.16B	107.28B	96.20B	85.08B
Total Growth	21.39%	7.35%	11.51%	13.07%	6.29%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
India	81.61B	67.88B	61.09B	53.70B	46.83B
India Growth	20.24%	11.10%	13.78%	14.66%	16.22%
United States	13.63B	11.00B	10.78B	11.62B	10.67B
United States Growth	23.90%	2.05%	-7.26%	8.89%	-15.52%
Germany	12.49B	11.39B	10.74B	9.28B	9.66B
Germany Growth	9.59%	6.09%	15.77%	-4.00%	-6.96%
Brazil	13.62B	11.00B	11.26B	9.35B	7.42B
Brazil Growth	23.82%	-2.29%	20.38%	26.07%	17.75%
Other Countries	18.45B	13.89B	13.41B	12.25B	10.49B
Other Countries Growth	32.81%	3.60%	9.40%	16.78%	0.59%
Total	139.80B	115.16B	107.28B	96.20B	85.08B
Total Growth	21.39%	7.35%	11.51%	13.07%	6.29%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 3, 2026

Data Sources Report a data error